Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management대사 기능 장애 관련 지방간 질환 및 코로나바이러스 질환 2019: 임상 관계 및 현재 관리Review Published on 2021-10-032022-09-10 Journal: Lipids in Health and Disease [Category] MERS, SARS, 유전자 메커니즘, [키워드] ACE2 active treatment acute respiratory syndrome acute respiratory syndrome coronavirus angiotensin angiotensin converting enzyme caused Clinical management contribute coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 infection COVID-19 patient deaths develop disease Disruption Drug-induced liver injury dysfunction enzyme exacerbated expression Fatty liver fatty liver disease Glucose Host hypoxic increased risk indicated infected with COVID-19 Injury International investigated Liver injury MAFLD management mechanism mechanisms metabolic Metabolic disorders metabolic dysfunction multifactorial pandemic of COVID-19 Patient patients with COVID-19 present prevalence of COVID-19 prevalent previous study progression promoted receptor recommendation respiratory respiratory infection respiratory outcomes SARS-CoV-2 severity of COVID-19 systemic inflammatory tendency the patient Treatment Viral Youth [DOI] 10.1186/s12944-021-01564-z PMC 바로가기 [Article Type] Review
Non-Alcoholic Fatty Liver Disease and COVID-19–Two Pandemics Hitting at the Same TimeReview Published on 2021-10-032022-10-30 Journal: Medicina [Category] COVID-19, MERS, SARS, [키워드] Admission Affect cardiovascular diseases clinical outcomes Comorbidities Complication COVID-19 COVID-19 pandemic disease explain Fatty liver group hypothese Impact liver Liver disease liver enzyme Liver injury Manifestations metabolic syndrome metabolic-associated fatty liver disease NAFLD no significant difference Non-alcoholic fatty liver disease organs patients with COVID-19 Patients with NAFLD reported Research severe COVID-19 shown the SARS-CoV-2 virus time [DOI] 10.3390/medicina57101057 PMC 바로가기 [Article Type] Review
Metabolic surgery may protect against admission for COVID-19 in persons with nonalcoholic fatty liver diseaseObservational Study Published on 2021-10-012022-10-05 Journal: Surgery for obesity and related diseases : official journal of the American [Category] SARS, 임상, [키워드] 95% CI 95% confidence interval Adiposity Admission Analysis appear cause chronic inflammation co-morbidities competing COVID-19 COVID-19 diagnosis COVID-19 in patient disease evaluate Factor Fatty liver fatty liver disease Healthcare system Hospitalization Hospitalized include increased risk increased the risk Inflammation Logistic regression medication treatment men metabolic metabolic and bariatric surgery. metabolic disease morbidity and mortality Mortality multiple imputation NAFLD NASH nonalcoholic fatty liver obesity Odds ratio operator Other Patient PCR peptide polymerase chain positive COVID-19 PROTECT receptor reduced risk Research risk risk factor SARS-CoV-2 screened Sex significantly steatohepatitis subgroups syndrome thrombosis Treatment variable selection Venous Thromboembolism visceral was used were assessed were used women [DOI] 10.1016/j.soard.2021.05.029 PMC 바로가기 [Article Type] Observational Study
Liver disease in the era of COVID-19: Is the worst yet to come?코로나19 시대의 간질환: 최악은 아직 오지 않았나?Review Published on 2021-09-282022-09-11 Journal: World journal of gastroenterology [Category] SARS, 치료기술, [키워드] Affect alcoholic beverages alcoholic hepatitis caused changes chronic chronic liver disease cirrhosis CLD Clinical practice Comfort consequence coronavirus disease Coronavirus disease 2019 Course COVID-19 COVID-19 pandemic disease disease course Donor drug Effect effort Fatty liver fatty liver disease had more health systems healthy Hepatitis Hepatocellular carcinoma Impact incidence Increases increases in initiated liver Liver cirrhosis Liver disease Liver transplantation Liver-related mortality management Modification monitoring system morbidity and mortality Mortality nonalcoholic fatty liver Nonalcoholic Fatty Liver Disease outcome overcome pandemic Patient Population prevented question reduction in robust seeking social isolation the disease transformation Treatment Viral hepatitis [DOI] 10.3748/wjg.v27.i36.6039 PMC 바로가기 [Article Type] Review
Role of fatty liver in coronavirus disease 2019 patients’ disease severity and hospitalization length: a case–control studyResearch Published on 2021-09-262022-10-31 Journal: European Journal of Medical Research [Category] COVID-19, [키워드] affected approach Chest chest CT-scan Complication control group coronavirus disease Coronavirus disease 2019 (COVID-19) COVID-19 COVID-19 pandemic COVID-19 patients determine develop disease severity Fatty liver Hospitalization Hospitalized hospitalized COVID-19 patient Hounsfield unit Illness severity liver Liver injury lobe lobes lung Non-COVID-19 patients pandemic Patient patients positive PCR test Prevalence prevalent Result Retrospective study role severe disease severity significantly higher significantly more statistical analysis Stay length the disease the SARS-CoV-2 [DOI] 10.1186/s40001-021-00590-y PMC 바로가기 [Article Type] Research
Multifactorial Basis and Therapeutic Strategies in Metabolism-Related Diseases대사 관련 질병의 다인자 기반 및 치료 전략Review Published on 2021-08-182022-09-10 Journal: Nutrients [Category] MERS, SARS, 유전자 메커니즘, [키워드] Basis cardiovascular disease cardiovascular diseases change Chronic diseases conditions Contamination coronavirus disease Coronavirus disease 2019 COVID-19 develop diabetes disease effective Factor Fatty liver fatty liver disease focus Genetic highlighting incidence individuals knowledge leads MAFLD metabolism mitigate modulate molecular mechanism NCDs Non-communicable disease non-communicable diseases obesity pathophysiology pharmacological interventions physical activity Prevalence progression reduce Research Risk factors SARS-CoV-2 virus severity Strategy Symptom the SARS-CoV-2 virus Therapeutic strategies Treatment [DOI] 10.3390/nu13082830 PMC 바로가기 [Article Type] Review
Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter study비알코올성 지방간 질환 환자에서 코로나19 예방접종의 안전성과 면역원성(CHESS2101): 다기관 연구Multicenter Study Published on 2021-08-012022-09-12 Journal: Journal of hepatology [Category] MERS, SARS, 진단, [키워드] Adverse reaction appear China concern coronavirus disease COVID-19 COVID-19 vaccination COVID-19 vaccine disease dose Efficacy Fatty liver headache inactivated Inactivated vaccine incidence injection injection site pain IQR male median median age Median BMI Mild multicenter NAFLD neutralizing antibody Neutralizing antibody response Neutralizing antibody titer outcome Pain Patient primary immunogenicity progressed raised response Safe Safety SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccine vaccination Vaccine were recorded [DOI] 10.1016/j.jhep.2021.04.026 PMC 바로가기 [Article Type] Multicenter Study
High Fibrosis-4 Index Is Related with Worse Clinical Outcome in Patients with Coronavirus Disease 2019 and Diabetes Mellitus: A Multicenter Observational StudyObservational Study Published on 2021-08-012022-10-05 Journal: Endocrinology and metabolism (Seoul, Korea) [Category] 임상, [키워드] 95% CI 95% confidence interval analyzed clinical Clinical course coronavirus disease COVID-19 COVID-19 mortality Diabetes Mellitus disease Evidence exhibited Factor Fatty liver FIB-4 Fibrosis-4 hazard ratio Hospital stay independent index Inpatient Laboratory Mortality mortality risk multicenter observational study Non-alcoholic fatty liver disease Odds ratio Patient predict Prevalence quarantine risk factor severe disease significantly significantly higher the Kaplan-Meier method the patient university hospital [DOI] 10.3803/EnM.2021.1040 PMC 바로가기 [Article Type] Observational Study
High Prevalence of Chronic Viral Hepatitis and Liver Fibrosis Among Mongols in Southern CaliforniaObservational Study Published on 2021-08-012023-06-13 Journal: Digestive diseases and sciences [Category] B형 간염, [키워드] cirrhosis Fatty liver hepatitis B hepatitis C Hepatitis Delta [DOI] 10.1007/s10620-020-06499-6 PMC 바로가기 [Article Type] Observational Study
Association Between Fatty Liver and Cirrhosis, Hepatocellular Carcinoma, and Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis BArticle Published on 2021-07-152023-06-13 Journal: The Journal of Infectious Diseases [Category] B형 간염, [키워드] cirrhosis Fatty liver HBsAg seroclearance Hepatitis B virus Hepatocellular carcinoma [DOI] 10.1093/infdis/jiaa739